Still seeking a cure
Daniel Lopez-Cruz, Head of Private Equity, Europe at Investcorp, said; “Sanos has all the key attributes that we look for in potential investments. It is an entrepreneurial organization with a clearly differentiated value proposition as well as a leading market position in a growing, resilient and mission-critical industry.
“Sanos has established itself as the partner of choice for pharma and biotech companies looking to conduct clinical trials for osteoarthritis, a condition for which there is currently a very high unmet medical need given the large and growing population of people being affected by it - and the fact that there is no cure for it at the moment.”